Thiard News@F4F

@newsen.bsky.social

1 day ago

Florida Cancer Specialists' Research Paves the Way for New Treatments for Ovarian Cancer Victims Florida Cancer Specialists has played a critical role in the FDA's approval of groundbreaking ovarian cancer therapies, improving patient outcomes significantly.

Florida Cancer Specialists' Research Paves the Way for New Treatments for Ovarian Cancer Victims #USA #Florida_Cancer_Specialists #Fort_Myers #KEYTRUDA #Ovarian_Cancer

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Anixa Biosciences to Present Ovarian Cancer CAR-T Trial Findings at SGO Annual Meeting Anixa Biosciences will unveil updates on its ovarian cancer CAR-T therapy clinical trial at the SGO Annual Meeting, highlighting innovative treatment strategies in gynecologic oncology.

Anixa Biosciences to Present Ovarian Cancer CAR-T Trial Findings at SGO Annual Meeting #United_States #Anixa_Biosciences #San_Jose #CAR-T_therapy #Ovarian_Cancer

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

Caris Life Sciences Unveils Innovative AI Insights to Detect Platinum Resistance in Ovarian Cancer Early Caris Life Sciences has introduced a novel AI-driven signature to identify early platinum resistance in ovarian cancer, enhancing treatment options for patients and clinicians.

Caris Life Sciences Unveils Innovative AI Insights to Detect Platinum Resistance in Ovarian Cancer Early #Caris_Life_Sciences #AI_Insights #Ovarian_Cancer

Thiard News@F4F

@newsen.bsky.social

1 month ago

Global Ovarian Cancer Research Consortium Launches AI Accelerator Grant with Microsoft Collaboration The Global Ovarian Cancer Research Consortium has unveiled its first AI Accelerator Grant with Microsoft’s support to enhance ovarian cancer research.

Global Ovarian Cancer Research Consortium Launches AI Accelerator Grant with Microsoft Collaboration #USA #New_York #Microsoft #AI_Research #Ovarian_Cancer

Thiard News@F4F

@newsen.bsky.social

2 months ago

Anixa Biosciences Reports Promising Survival Rates in Ovarian Cancer CAR-T Trial with Dose Escalation Approval Anixa Biosciences has reported positive patient survival data from its CAR-T trial for ovarian cancer, leading to new dosing approvals for further study.

Anixa Biosciences Reports Promising Survival Rates in Ovarian Cancer CAR-T Trial with Dose Escalation Approval #USA #Anixa_Biosciences #San_Jose #CAR-T_therapy #Ovarian_Cancer

Thiard News@F4F

@newsen.bsky.social

2 months ago

Eli Lilly's Sofetabart Mipitecan Gains FDA Breakthrough Status for Ovarian Cancer Treatment Eli Lilly's sofetabart mipitecan has received Breakthrough Therapy designation from the FDA for treating platinum-resistant ovarian cancer, signaling promising new developments.

Eli Lilly's Sofetabart Mipitecan Gains FDA Breakthrough Status for Ovarian Cancer Treatment #United_States #Indianapolis #Eli_Lilly #Ovarian_Cancer #Sofetabart_Mipitecan

Thiard News@F4F

@newsen.bsky.social

3 months ago

Navigating Life's Challenges: A Cancer Survivor's Journey to Finding Hope and Healing Cynthia Dano shares her inspiring story of overcoming ovarian cancer twice, revealing her insights on healing, resilience, and the beauty of life amidst struggles.

Navigating Life's Challenges: A Cancer Survivor's Journey to Finding Hope and Healing #United_States #Olympia #Ovarian_Cancer #Healing_Journey #Cynthia_Dano

Thiard News@F4F

@newsen.bsky.social

3 months ago

Emerging Evidence Advances Nationwide Talcum Powder Lawsuits Over Ovarian Cancer Risks Talc litigation intensifies as evidence linking Johnson's Baby Powder to ovarian cancer mounts, prompting new actions in courts nationwide.

Emerging Evidence Advances Nationwide Talcum Powder Lawsuits Over Ovarian Cancer Risks #United_States #Los_Angeles #Johnson_&_Johnson #Ovarian_Cancer #Talcum_Powder

Thiard News@F4F

@newsen.bsky.social

3 months ago

California Jury Awards $40 Million Against Johnson & Johnson Over Talcum Powder Cancer Case A Los Angeles jury has ruled in favor of plaintiffs, awarding $40 million to women affected by ovarian cancer linked to Johnson & Johnson's talc-based powder, highlighting major safety concerns.

California Jury Awards $40 Million Against Johnson & Johnson Over Talcum Powder Cancer Case #United_States #Los_Angeles #Johnson_&_Johnson #Ovarian_Cancer #Talcum_Powder

Thiard News@F4F

@newsen.bsky.social

4 months ago

Ovarian Cancer Research Alliance Establishes New Center to Elevate Advocacy Efforts for Gynecologic Cancers Ovarian Cancer Research Alliance has unveiled its Center for Public Policy, aiming to enhance advocacy and represent gynecologic cancer patients nationally. Discover their new tools and initiatives.

Ovarian Cancer Research Alliance Establishes New Center to Elevate Advocacy Efforts for Gynecologic Cancers #USA #New_York #Gynecologic_Cancer #Ovarian_Cancer #OCRA

Thiard News@F4F

@newsen.bsky.social

5 months ago

Mercy BioAnalytics Reveals Groundbreaking Blood Test for Early Ovarian Cancer Detection Mercy BioAnalytics has published a study showcasing a blood test that detects ovarian cancer with unprecedented effectiveness, potentially changing detection methods.

Mercy BioAnalytics Reveals Groundbreaking Blood Test for Early Ovarian Cancer Detection #United_States #Waltham #Blood_Test #Ovarian_Cancer #Mercy_BioAnalytics

Thiard News@F4F

@newsen.bsky.social

6 months ago

Strengthening the Future of Platinum-Resistant Ovarian Cancer Treatment: Emerging Strategies and Market Dynamics The platinum-resistant ovarian cancer treatment market is expanding with innovative therapies aimed at addressing unmet patient needs, promising better outcomes for patients.

Strengthening the Future of Platinum-Resistant Ovarian Cancer Treatment: Emerging Strategies and Market Dynamics #United_States #Las_Vegas #Clinical_Trials #targeted_therapies #Ovarian_Cancer

Thiard News@F4F

@newsen.bsky.social

6 months ago

Oncoinvent Unveils Encouraging Results from Phase 1 Trial of Radspherin for Ovarian Cancer Treatment Oncoinvent ASA announces promising results from a Phase 1 trial of Radspherin, showcasing its potential in treating ovarian cancer. This marks a key advancement in cancer therapy.

Oncoinvent Unveils Encouraging Results from Phase 1 Trial of Radspherin for Ovarian Cancer Treatment #Norway #Oslo #Radspherin #Ovarian_Cancer #Oncoinvent

Thiard News@F4F

@newsen.bsky.social

6 months ago

Oncoinvent Announces Encouraging Results from Phase 1 Trial of Radspherin® Targeting Ovarian Cancer Oncoinvent ASA reveals promising data from its Phase 1 trial of Radspherin®, demonstrating potential in preventing ovarian cancer progression.

Oncoinvent Announces Encouraging Results from Phase 1 Trial of Radspherin® Targeting Ovarian Cancer #Norway #Oslo #Radspherin #Ovarian_Cancer #Oncoinvent

Thiard News@F4F

@newsen.bsky.social

6 months ago

Dr. Scott Kamelle Launches Award for Ovarian Cancer Survivors Honoring Their Journey The Dr. Scott Kamelle Award now invites ovarian cancer survivors to share their powerful stories, highlighting resilience and strength as they apply for this unique honor.

Dr. Scott Kamelle Launches Award for Ovarian Cancer Survivors Honoring Their Journey #USA #Milwaukee #Ovarian_Cancer #Dr._Scott_Kamelle #Survivor_Award

Thiard News@F4F

@newsen.bsky.social

6 months ago

AbbVie Unveils ELAHERE® Pricing Strategy for UK Market, Equal to US AbbVie has announced a pricing strategy for ELAHERE® in the UK, aligning its costs with those in the US to extend its innovative cancer treatment to more patients.

AbbVie Unveils ELAHERE® Pricing Strategy for UK Market, Equal to US #United_Kingdom #AbbVie #North_Chicago #Ovarian_Cancer #ELAHERE

Thiard News@F4F

@newsen.bsky.social

6 months ago

Precision Biologics to Showcase Promising New ADC for Ovarian Cancer at AACR Conference Precision Biologics will present data on a novel antibody-drug conjugate targeting ovarian cancer at the AACR conference, highlighting its efficacy and potential.

Precision Biologics to Showcase Promising New ADC for Ovarian Cancer at AACR Conference #USA #Denver #ADC #Ovarian_Cancer #Precision_Biologics

Thiard News@F4F

@newsen.bsky.social

7 months ago

Anixa Biosciences Achieves Milestone in Ovarian Cancer CAR-T Therapy Trials Anixa Biosciences has completed dosing the fourth cohort in its CAR-T clinical trial for ovarian cancer, with encouraging early survival results.

Anixa Biosciences Achieves Milestone in Ovarian Cancer CAR-T Therapy Trials #United_States #Anixa_Biosciences #San_Jose #CAR-T_therapy #Ovarian_Cancer

Thiard News@F4F

@newsen.bsky.social

7 months ago

Wrapped in Love and Kelly Ripa Team Up for Ovarian Cancer Awareness Socks Kelly Ripa collaborates with Wrapped in Love to launch limited-edition socks for Ovarian Cancer Awareness Month, with proceeds aiding research.

Wrapped in Love and Kelly Ripa Team Up for Ovarian Cancer Awareness Socks #USA #Sterling_Heights #Ovarian_Cancer #Kelly_Ripa #Wrapped_in_Love

Thiard News@F4F

@newsen.bsky.social

7 months ago

Mercy BioAnalytics Secures $59 Million in Funding for Cancer Detection Initiatives Mercy BioAnalytics has successfully closed a $59 million Series B financing round aimed at advancing its early cancer detection programs, marking a significant milestone in oncology diagnostics.

Mercy BioAnalytics Secures $59 Million in Funding for Cancer Detection Initiatives #United_States #Waltham #cancer_detection #Ovarian_Cancer #Mercy_BioAnalytics

Thiard News@F4F

@newsen.bsky.social

7 months ago

Oncoinvent ASA's Strong Progress in Ovarian Cancer Research Report Oncoinvent ASA has reported significant advancements in its Phase 2 ovarian cancer trial, showcasing financial discipline and corporate development.

Oncoinvent ASA's Strong Progress in Ovarian Cancer Research Report #Norway #Oslo #Radspherin #Ovarian_Cancer #Oncoinvent

Thiard News@F4F

@newsen.bsky.social

7 months ago

Anixa Biosciences Progresses with Ovarian Cancer CAR-T Clinical Trial by Treating Second Patient Anixa Biosciences has treated the second patient in the fourth cohort of its CAR-T clinical trial for ovarian cancer, marking a significant milestone.

Anixa Biosciences Progresses with Ovarian Cancer CAR-T Clinical Trial by Treating Second Patient #USA #Anixa_Biosciences #San_Jose #CAR-T_therapy #Ovarian_Cancer

Philippa B

@philippabagley.bsky.social

8 months ago

How Cancer and Service Inspired Beth Hildbrand's Mission to Empower and Uplift Ready to improve your own journey!?  Head over to Skool and check out the https://www.skool.com/journeytopurpose/about?ref=a7f012002d894fa1aae88fdd15e34cdb In this episode, Philippa Bagley interviews Beth Hildbrand, the CEO of Resilient Stars Marketing, who shares her inspiring journey of resilience through personal challenges, including her battle with ovarian cancer. Beth discusses the importance of embracing change, the role of digital marketing in her life, and her passion for helping others through her non-profit organization aimed at supporting trauma survivors. The conversation also touches on the impact of AI in marketing and the significance of living in the present moment. Key Takeaways - Resilience is key in accepting those things we cannot control. - It's important to embrace change and challenges in life. - Digital marketing can be a creative outlet and a career path. - AI is transforming the marketing landscape and should be embraced. - Finding purpose in work can lead to greater fulfillment. - Living in the present moment is crucial for mental well-being. - Letting go of negativity can lead to personal growth. - Building a non-profit can be a way to give back to the community. - Personal experiences can shape one's professional journey. - Consistency in content creation is vital for success. Sound Bites - "AI is going to be amazing." - "Everything costs more and takes longer." - "You can choose to be happy in this moment." About Beth Hildbrand Beyond technology, her commitment extends to supporting those who have served and those in need. In partnership with a leading Health & Wellness company, Beth and her company engage in promoting educational seminars that focus on health benefits and wellness practices. This initiative is close to her heart, driven by her own journey as a cancer survivor, and aims to spread vital health information to improve quality of life. https://www.youtube.com/@bethtalksRSM https://www.instagram.com/hellobethe/ https://www.linkedin.com/in/bethtalksrsm https://resilientstarsmarketing.com/ https://www.facebook.com/elizabethit2021 About Philippa Bagley I’m a Professional Speaker and Therapist with a diverse background that includes military service and teaching.Like many people, I grew tired of corporate life and retrained in a range of therapies. Now, I combine my extensive qualifications to assist individuals and organisations in boosting their communication, connection, and confidence. This enables them to make a significant impact on the world.I am passionately committed to mentoring clients, helping them overcome issues related to confidence, anxiety, and trauma, unlocking their potential, achieving their highest goals, and building mental resilience.

📣 New Podcast! "How Cancer and Service Inspired Beth Hildbrand's Mission to Empower and Uplift" on @Spreaker #adversity #ai #branding #cancer #digital #entrepreneurship #financial_freedom #human #iraq #marketing #mindset #nonprofit #ovarian_cancer #overcome #recovery #resilience #survivor

Thiard News@F4F

@newsen.bsky.social

8 months ago

New Research Reveals Hidden Ovarian Cancer Cells in Patients Labeled as 'Cancer-Free' A recent study uncovers hidden cancer cells in 42% of patients declared cancer-free after treatment, pointing to new therapy avenues.

New Research Reveals Hidden Ovarian Cancer Cells in Patients Labeled as 'Cancer-Free' #United_States #Cambridge #Ovarian_Cancer #Break_Through_Cancer #MRD

Thiard News@F4F

@newsen.bsky.social

8 months ago

Compugen to Unveil COM701 Phase 1 Trials Analysis at ESMO 2025 in Berlin Discover Compugen's upcoming presentation focusing on the pooled analysis of COM701 Phase 1 trials for platinum-resistant ovarian cancer at ESMO 2025.

Compugen to Unveil COM701 Phase 1 Trials Analysis at ESMO 2025 in Berlin #Israel #Compugen #Holon #Ovarian_Cancer #COM701

Thiard News@F4F

@newsen.bsky.social

8 months ago

Compugen Initiates Groundbreaking Trial for COM701 in Ovarian Cancer Treatment Compugen has officially started dosing patients in a global trial for COM701, an innovative therapy for platinum-sensitive ovarian cancer, aiming for improved patient outcomes.

Compugen Initiates Groundbreaking Trial for COM701 in Ovarian Cancer Treatment #Israel #Compugen #Holon #Ovarian_Cancer #COM701

Thiard News@F4F

@newsen.bsky.social

8 months ago

Human Longevity, Inc. Enhances $1 Million Initiative for Late-Stage Ovarian Cancer Prevention Human Longevity, Inc. expands its $1 million cancer prevention initiative to include late-stage ovarian cancer, promoting early detection and treatment.

Human Longevity, Inc. Enhances $1 Million Initiative for Late-Stage Ovarian Cancer Prevention #USA #South_San_Francisco #Human_Longevity #Ovarian_Cancer #Avantect

Thiard News@F4F

@newsen.bsky.social

9 months ago

Anixa Biosciences Secures New U.S. Patent for Innovative Ovarian Cancer Vaccine Technology Anixa Biosciences has announced the issuance of a U.S. patent for its groundbreaking ovarian cancer vaccine, enhancing its treatment offerings in oncology.

Anixa Biosciences Secures New U.S. Patent for Innovative Ovarian Cancer Vaccine Technology #USA #Anixa_Biosciences #San_Jose #Ovarian_Cancer #U.S._Patent

Thiard News@F4F

@newsen.bsky.social

9 months ago

Bio-Thera Solutions Launches Phase 3 Trial for Groundbreaking Ovarian Cancer Treatment Bio-Thera Solutions has initiated a Phase 3 clinical trial for BAT8006, an innovative treatment for platinum-resistant ovarian cancer, showing promising early results.

Bio-Thera Solutions Launches Phase 3 Trial for Groundbreaking Ovarian Cancer Treatment #China #Guangzhou #Bio-Thera_Solutions #Ovarian_Cancer #BAT8006

Thiard News@F4F

@newsen.bsky.social

9 months ago

Global Ovarian Cancer Drugs Market Anticipated to Reach $4.23 Billion by 2031 The global ovarian cancer drugs market is expected to grow significantly, reaching $4.23 billion by 2031, driven by rising incidences and advancements in treatments.

Global Ovarian Cancer Drugs Market Anticipated to Reach $4.23 Billion by 2031 #USA #New_York #Ovarian_Cancer #Targeted_Therapy #PARP_inhibitors